BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The BioCalendar - ECPv6.18.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://thebiocalendar.com
X-WR-CALDESC:Events for The BioCalendar
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20230101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240106
DTEND;VALUE=DATE:20240108
DTSTAMP:20231108T204606Z
CREATED:20231108T204606Z
LAST-MODIFIED:20231108T204606Z
UID:4899-1704499200-1704671999@thebiocalendar.com
SUMMARY:Longwood Healthcare Leaders San Francisco CEO
DESCRIPTION:Longwood Healthcare Leaders San Francisco CEO brings together leading biopharma CEOs\, heads of R&D\, top academic researchers\, and life science investors the weekend prior to the JP Morgan Healthcare Conference for off-the-record discussion\, co-hosted by Stanford Med Dean Lloyd Minor and former Stanford President Marc Tessier-Lavigne\, held at the Four Seasons San Francisco. \nJoin us for an intimate event with leaders in the industry.
URL:https://thebiocalendar.com/event/longwood-healthcare-leaders-san-francisco-ceo/
LOCATION:San Francisco\, CA\, San Francisco\, CA\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240107
DTEND;VALUE=DATE:20240108
DTSTAMP:20231108T203846Z
CREATED:20231108T203846Z
LAST-MODIFIED:20231108T203846Z
UID:4895-1704585600-1704671999@thebiocalendar.com
SUMMARY:Dermatology Summit 2024
DESCRIPTION:The mission of the Dermatology Summit is to build a community of people who are excited about innovation in dermatology.\nThis conference uniquely brings together members of the financial community and business leaders from established and emerging companies in the dermatology space to help foster investment and partnerships in the next generation of dermatology companies and products.
URL:https://thebiocalendar.com/event/dermatology-summit-2024/
LOCATION:San Francisco\, CA\, San Francisco\, CA\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240107
DTEND;VALUE=DATE:20240108
DTSTAMP:20231108T204058Z
CREATED:20231108T204058Z
LAST-MODIFIED:20231108T204058Z
UID:4896-1704585600-1704671999@thebiocalendar.com
SUMMARY:7th Annual Neuroscience Innovation Forum
DESCRIPTION:We are pleased to announce that the 7th Annual Neuroscience Innovation Forum (#Sachs_NIF) will take place at the Marines Memorial Club\, San Francisco on the 7th of January 2024\, a day before the JP Morgan meeting and the Virtual Week will take place the week after\, from the 16th – 18th of January. \nThe forum\, positioned at the beginning of JPM week\, focuses on the latest developments across key areas of Neuroscience which are currently drawing widespread investor interest. The main programme for the 7th Annual NIF will feature more than 8 hours of high-level keynotes and panel discussions addressing the important advances in therapeutic\, neurotech and diagnostics fields. Industry leaders will address the following topics: \nSunday\, 7th of January: \n\nIndustry Roundtable\nAdvances in the Treatment of Alzheimer’s & Other Cognitive Disorders Panel\nExploring New Modalities for Rare & Orphan Neurological Diseases Panel\nNew Approaches to Neuro Psychiatric Disorders Panel\nThe Future of Psychedelics: Innovation\, Regulation & Investment Opportunities Panel\nNew Frontiers in Neuro Stimulation & Implants: Changing Patients’ Lives Panel\nInvestor Roundtable\n\nIn-Person Meetings – 7th of January \nVirtual Meetings via Online Meeting System - 16th – 18th of January \nNetworking Reception – 7th of January \nThe target audience are buy and sell side analysts from investment banks and funds\, alongside partnering executives from pharma\, biotech\, medtech\, neurotech and diagnostics companies. We anticipate over 300 delegates in-person and 30+ company presentations by established and emerging companies. This will include a limited number of live presentations taking place in dedicated presentation tracks\, alongside virtual company showcases\, which will be available on demand. Recorded sessions will also be added on demand on the event’s portal during the virtual week. \nThe In-Person meetings will be taking place on the 7th of January\, while virtual meetings will take place on the 16th – 18th of January. For the virtual meetings\, the system will allow you to have a secure audio/video call\, as well as option to present slides using a screen share function and we will have a dedicated room for in-person meetings. The conference will be held in the Pacific Standard Time (PST) zone. \nThe physical programme will consist of the usual panels and keynotes\, which will be available on demand for the virtual audience\, the week after JP Morgan meeting. Additionally\, there will be pre-arranged in-person meetings\, live and on demand company showcases and a reception. The in-person event will be followed by an additional week of virtual meetings available through the audio/video online meeting system\, starting from the 16th of January.
URL:https://thebiocalendar.com/event/7th-annual-neuroscience-innovation-forum/
LOCATION:San Francisco\, CA\, San Francisco\, CA\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240107
DTEND;VALUE=DATE:20240108
DTSTAMP:20231122T225555Z
CREATED:20231122T225555Z
LAST-MODIFIED:20231122T225555Z
UID:4940-1704585600-1704671999@thebiocalendar.com
SUMMARY:UC Davis Health Future & Health Summit at JPM
DESCRIPTION:The UC Davis Future and Health CEO summit\, in partnership with Decimal Health\, will take place during the JP Morgan 42nd Healthcare Summit to be held in San Francisco. \nThe Summit is an invitation-only event taking place on January 7th 2024 at the City Club of San Francisco where we will bring together 250+ CEOs and the leadership teams of Health Systems\, Health Plans\, and Biopharma. \nJoin the waitlist today. We will inform you once your seat is confirmed. \nAnd if you want to see the type of event this will be\, here are the videos from our JP Morgan CEO event in January 2022: https://bit.ly/3FxtT2h \nThis summit’s theme will focus on the impact of the changing health investment landscape\, and the business of healthcare. More specifically\, we will focus on how health systems operate\, impacts on patient care\, remote patient care\, generative AI\, and more.
URL:https://thebiocalendar.com/event/uc-davis-health-future-health-summit-at-jpm/
LOCATION:San Francisco\, CA\, San Francisco\, CA\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240107
DTEND;VALUE=DATE:20240108
DTSTAMP:20231206T214730Z
CREATED:20231206T214730Z
LAST-MODIFIED:20231206T214730Z
UID:4985-1704585600-1704671999@thebiocalendar.com
SUMMARY:Jones Day – MSQ Global Biopharma Symposium & Networking Reception
DESCRIPTION:The Jones Day – MSQ Global Biopharma Symposium & Networking Reception will return to San Francisco\, California! \nCo-hosted by Jones Day & MSQ Ventures\, with our supporting organizations BioCentury Inc.\, The BayHelix Group\, and BioAroundWorld. \nOur guest lists includes key industry leaders\, professionals\, and potential collaborators such as Merck\, Daiichi Sankyo\, Inc.\, Roche\, Jiangsu Hengrui Pharmaceuticals Co.\, Ltd.\, Henlius | 复宏汉霖\, NeuShen Therapeutics\, Panacea Venture\, Quan Capital 泉创资本\, Overland Pharmaceuticals\, Novartis AG\, Sherpa Capital\, Polaris Pharmaceuticals Inc.\, Erasca\, Inc.\, Captor Therapeutics SA\, Duality Biologics\, Dermaliq Therapeutics\, UniXell Biotechnology\, and many more. \nDive into discussions on the cutting-edge trends and innovations shaping the regional-global biopharma landscape. Engage in thought-provoking panels\, connect with top-tier biopharma executives\, and discover new avenues for business growth.
URL:https://thebiocalendar.com/event/jones-day-msq-global-biopharma-symposium-networking-reception/
LOCATION:San Francisco\, CA\, San Francisco\, CA\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240107
DTEND;VALUE=DATE:20240108
DTSTAMP:20231206T215033Z
CREATED:20231206T215033Z
LAST-MODIFIED:20231206T215033Z
UID:4986-1704585600-1704671999@thebiocalendar.com
SUMMARY:7th BFC Global Healthcare BD & Investment Conference
DESCRIPTION:During the last three years\, we have seen explosive growth in out-licensing of Chinese innovations to global biopharma companies. \n\nNovo acquired the leading asset from KBP for $1.3B USD\nJanssen struck a $245M upfront payment licensing deal with Cellular Biomedicine Group (CBMG) for CAR -T cancer therapies\nMerck moved forward with a $9.3B ADC deal (including $175M upfront) with Kelun-Biotech for a portfolio of ADC assets\nBioNTech in-licensed two ADC assets from Duality Bio\, paying $170 million upfront\, plus milestone and royalty payments\n\nIn addition to these examples\, we are witnessing new out-licensing deals between Chinese biotech companies and global pharma companies almost every week. These deals stem from the emerging remarkable scientific discoveries (Great Science) from leading Chinese biotech and medtech companies. However\, despite these advancements\, there are still major challenges to overcome\, including reimbursement\, product commercialization\, venture financing\, and entry to the global market. The purpose of this conference is to promote industry growth through the participation and collaboration of multiple parties around the world. \nThe conference will highlight key trends in the following areas: \n\nBiotech capital market outlook and investment opportunities in the US and Asia\nLicensing trends in 2023 among Asian and US Pharmaceutical and Biopharma companies\nLeading biotech company road show presentations\n\nSenior executives from more than 600 public & private healthcare companies across the biopharmaceuticals\, IVD\, medical device\, and healthcare services sectors attended our previous event in 2023. More than 300 PE and VC investors from over 100 firms were also present. The conference is an ideal setting for networking with the senior executives of your potential partners. Company management teams and investors will be able to participate in one-on-one and small-group meetings through BFC Group.
URL:https://thebiocalendar.com/event/7th-bfc-global-healthcare-bd-investment-conference/
LOCATION:San Francisco\, CA\, San Francisco\, CA\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240107
DTEND;VALUE=DATE:20240108
DTSTAMP:20231206T215913Z
CREATED:20231206T215913Z
LAST-MODIFIED:20231206T215913Z
UID:4988-1704585600-1704671999@thebiocalendar.com
SUMMARY:VALID AI + Future & Health Summit at JPM
DESCRIPTION:UC Davis Health CoLab brings 350 CEOs and senior leaders in San Francisco to discuss the impact of investments in digital health and AI.
URL:https://thebiocalendar.com/event/valid-ai-future-health-summit-at-jpm/
LOCATION:San Francisco\, CA\, San Francisco\, CA\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20240107T073000
DTEND;TZID=UTC:20240107T180000
DTSTAMP:20231108T204504Z
CREATED:20231108T204504Z
LAST-MODIFIED:20231108T204504Z
UID:4898-1704612600-1704650400@thebiocalendar.com
SUMMARY:2024 Pre-JPM CTIC 7th Healthcare Summit
DESCRIPTION:Join us for the 2024 Pre-JPM CTIC 7th Healthcare Summit! This exciting in-person event will take place at the 5th Floor of InterContinental at 888 Howard Street\, San Francisco\, featuring Bob Langer as our keynote speaker on Sunday\, January 7\, 2024 ! \nThe Summit is a must-attend gathering for healthcare professionals\, entrepreneurs\, and innovators. Get ready to dive into the latest trends\, advancements\, and challenges in the healthcare industry. \nWith a focus 2024 Pre-JPM CTIC 7th Healthcare Summit on collaboration and knowledge sharing\, this summit offers a unique opportunity to network with like-minded individuals and expand your professional connections. Engage in insightful discussions\, attend thought-provoking panels\, and gain valuable insights from renowned speakers. \nA selected global healthare companies with cutting-edge technologies will be showcased. Please apply for presenting here! \nDon’t miss out on this incredible chance to stay ahead in the rapidly evolving healthcare landscape. Join us at the 2024 Pre-JPM CTIC 7th Healthcare Summit and be part of the future of healthcare!
URL:https://thebiocalendar.com/event/2024-pre-jpm-ctic-7th-healthcare-summit/
LOCATION:San Francisco\, CA\, San Francisco\, CA\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20240107T083000
DTEND;TZID=UTC:20240107T100000
DTSTAMP:20231206T220116Z
CREATED:20231206T220116Z
LAST-MODIFIED:20231206T220116Z
UID:4990-1704616200-1704621600@thebiocalendar.com
SUMMARY:What Is Up For Biopharmaceutical Policy In 2024?
DESCRIPTION:Attendees will gain an understanding of major policy changes and federal policy debates in 2024. The focus is anticipating the impact of these policy changes on product approval\, launch and revenue expectations in the U.S. for in line and pipeline biopharmaceuticals. \nTopics will include: Inflation Reduction Act Implementation\, Anticipated Challenges in IP\, Focus on M&A across the healthcare industry\, and the overlay of drug pricing in all these debates. \nPanel Discussion Moderated by John Stanford\, Executive Director of Incubate\, featuring: \nSenator Richard Burr \nKirsten Axelsen\, Senior Policy Advisor\, DLA Piper \nGaurav Gupta\, Managing Partner\, J.P. Morgan Life Sciences Private Capital
URL:https://thebiocalendar.com/event/what-is-up-for-biopharmaceutical-policy-in-2024/
LOCATION:San Francisco\, CA\, San Francisco\, CA\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20240107T090000
DTEND;TZID=UTC:20240107T173000
DTSTAMP:20231108T204408Z
CREATED:20231108T204408Z
LAST-MODIFIED:20231108T204408Z
UID:4897-1704618000-1704648600@thebiocalendar.com
SUMMARY:5th Annual CERSI Innovations in Regulatory Science Summit
DESCRIPTION:The UCSF-Stanford Center of Excellence in Regulatory Science and Innovation (UCSF-Stanford CERSI) is pleased to present the fifth annual CERSI Innovations in Regulatory Science Summit\, a gathering of leaders in the academia\, industry\, and regulatory sectors to discuss the role of regulatory science in medical product development. \nThe 2024 CERSI Innovations in Regulatory Science Summit will have a major focus on emerging issues in regulatory science. The summit will include panels on medical misinformation and its impact on public health\, regulatory decision making among different countries\, manufacturing and supply chain of medical products\, and the return of our exciting panel featuring former FDA Commissioners on the latest issues facing the Agency. New this year will be an FDA Center Directors panel as well as debates on exciting topics in regulatory science. \nThe goal of the summit is to stimulate discussion across sectors and to critically consider lessons learned and scientific issues that need addressing to expeditiously and safely advance the development\, approval\, and monitoring of medical products.
URL:https://thebiocalendar.com/event/5th-annual-cersi-innovations-in-regulatory-science-summit/
LOCATION:San Francisco\, CA\, San Francisco\, CA\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20240107T130000
DTEND;TZID=UTC:20240107T180000
DTSTAMP:20231206T215203Z
CREATED:20231206T215203Z
LAST-MODIFIED:20231206T215203Z
UID:4987-1704632400-1704650400@thebiocalendar.com
SUMMARY:2024 SAPA Investment Forum @JPM: Global Collaboration in Healthcare
DESCRIPTION:Join the Sino-American Pharmaceutical Professionals Association (SAPA) for an exclusive in-person event during the 42nd JP Morgan Healthcare Conference week in San Francisco\, California. This is an unparalleled opportunity: \n\nEngage with prominent investors\, consultants\, and legal experts to gain insights on market trends and strategic business guidance.\nConnect with life science industry leaders and understand their strategies to navigate market challenges.\nTo showcase company profile and forge potential collaborations.\n\nAgenda:\nI. Panel Discussion \n\nGlobal Investment Trend & Entrepreneurship\nBusiness Development & Global Collaboration\n\nII. Reception
URL:https://thebiocalendar.com/event/2024-sapa-investment-forum-jpm-global-collaboration-in-healthcare/
LOCATION:San Francisco\, CA\, San Francisco\, CA\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20240107T170000
DTEND;TZID=UTC:20240107T200000
DTSTAMP:20231205T214528Z
CREATED:20231205T214528Z
LAST-MODIFIED:20231205T214528Z
UID:4983-1704646800-1704657600@thebiocalendar.com
SUMMARY:EWIB-SF Luminary Event
DESCRIPTION:Healthcare capitalization has a hangover. The boom of investment in 2021 and early 2022 led to some company over-valuations\, which\, coupled with geopolitical and environmental issues\, has led to a major correction in the markets. \nWhat’s a company seeking working capital to do? \nJoin EWIB-San Francisco for an informative panel conversation exploring alternative funding opportunities for life sciences companies during the current economic downturn. Food and drinks will be served. \nAgenda: \n\n5:00 – 6:00 PM Check-in and networking\n6:00 – 7.00 PM Panel discussion\n7:00 – 8:00 PM QA and networking\n\nThe distinguished panel includes: \n\nLisa Alderson — interim CEO and Board Director\, AdelaBio\, EIR @Illumina Venture\nCelia Economides\, M.P.H — Executive Vice President and Chief Financial Officer\, Gritstone Bio\nMarian Nakada\, Ph.D. — Vice President\, Venture Investments\, J&J Innovations\nRamlah Nehring\, Ph.D. — Head Diagnostics Partnering\, Strategy and Transactions
URL:https://thebiocalendar.com/event/ewib-sf-luminary-event/
LOCATION:San Francisco\, CA\, San Francisco\, CA\, United States
END:VEVENT
END:VCALENDAR